Innovation Center, Palo Alto Medical Foundation, Palo Alto, CA 94040, USA.
J Am Med Inform Assoc. 2013 May 1;20(3):526-34. doi: 10.1136/amiajnl-2012-001263. Epub 2012 Nov 20.
To evaluate an online disease management system supporting patients with uncontrolled type 2 diabetes.
Engaging and Motivating Patients Online With Enhanced Resources for Diabetes was a 12-month parallel randomized controlled trial of 415 patients with type 2 diabetes with baseline glycosylated hemoglobin (A1C) values ≥7.5% from primary care sites sharing an electronic health record. The intervention included: (1) wirelessly uploaded home glucometer readings with graphical feedback; (2) comprehensive patient-specific diabetes summary status report; (3) nutrition and exercise logs; (4) insulin record; (5) online messaging with the patient's health team; (6) nurse care manager and dietitian providing advice and medication management; and (7) personalized text and video educational 'nuggets' dispensed electronically by the care team. A1C was the primary outcome variable.
Compared with usual care (UC, n=189), patients in the intervention (INT, n=193) group had significantly reduced A1C at 6 months (-1.32% INT vs -0.66% UC; p<0.001). At 12 months, the differences were not significant (-1.14% INT vs -0.95% UC; p=0.133). In post hoc analysis, significantly more INT patients had improved diabetes control (>0.5% reduction in A1C) than UC patients at 12 months (69.9 (95% CI 63.2 to 76.5) vs 55.4 (95% CI 48.4 to 62.5); p=0.006).
A nurse-led, multidisciplinary health team can manage a population of diabetic patients in an online disease management program. INT patients achieved greater decreases in A1C at 6 months than UC patients, but the differences were not sustained at 12 months. More INT than UC patients achieved improvement in A1C (>0.5% decrease). Trial registered in clinical trials.gov: #NCT00542204.
评估一个支持未控制 2 型糖尿病患者的在线疾病管理系统。
Engaging and Motivating Patients Online With enhanced Resources for Diabetes 是一项为期 12 个月的平行随机对照试验,纳入了来自共享电子健康记录的初级保健站点的 415 名基线糖化血红蛋白(A1C)值≥7.5%的 2 型糖尿病患者。干预措施包括:(1)通过无线方式上传血糖仪读数并提供图形反馈;(2)全面的患者特定糖尿病状况摘要报告;(3)营养和运动记录;(4)胰岛素记录;(5)与患者的健康团队进行在线消息传递;(6)护士护理经理和营养师提供建议和药物管理;以及(7)由护理团队以电子方式分发个性化的文字和视频教育“小块”。A1C 是主要结局变量。
与常规护理(UC,n=189)相比,干预组(INT,n=193)患者的 A1C 在 6 个月时显著降低(-1.32% INT 与-0.66% UC;p<0.001)。在 12 个月时,差异无统计学意义(-1.14% INT 与-0.95% UC;p=0.133)。事后分析显示,INT 组在 12 个月时达到 A1C 改善(A1C 降低>0.5%)的患者比例显著高于 UC 组(69.9(95%CI 63.2 至 76.5)与 55.4(95%CI 48.4 至 62.5);p=0.006)。
由护士领导的多学科医疗团队可以在在线疾病管理计划中管理一群糖尿病患者。INT 组患者在 6 个月时 A1C 的降低幅度大于 UC 组,但在 12 个月时差异不再显著。INT 组比 UC 组有更多的患者实现了 A1C 的改善(A1C 降低>0.5%)。该试验在临床试验.gov 上注册:#NCT00542204。